Back to search
Langerhans Cell Histiocytosis (LCH)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Langerhans Cell Histiocytosis (LCH) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Langerhans Cell Histiocytosis (LCH) trials you may qualify forThis phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients with Langerhans cell histiocytosis that…
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patient…
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
The purpose of this Phase II clinical trial is to establish the safety and effectiveness of trametinib, a targeted therapy, for the treatment of newly or recent…
Prospective, interventional, open, randomized, single-center, non-commercial clinical trial to optimize treatment and dosage of vemurafenib in juvenile patients…
Prospective, interventional, open, randomized, single-center, non-commercial clinical trial to optimize treatment and dosage of trametinib in juvenile patients…
The purpose of this study is to try to understand how histopcytosis can cause symptoms or problems in the brain. The tests being done in the study will look at…
The purpose of this study is to use agnostic genomic evaluation using whole exome sequencing (WES) of a variety of rare hematologic diseases grouped under rare…
This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have recurred or spread to other places in the…